|
Sacituzumab (anti-TROP2)
|
Ab169313-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1796566-95-4 |
10mg
|
¥ 9999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Pamrevlumab (anti-CTGF)
|
Ab169278-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
946415-13-0 |
5mg
|
¥ 4749.9
|
现货 |
|
0 |
阿拉丁 |
|
Pamrevlumab (anti-CTGF)
|
Ab169278-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
946415-13-0 |
1mg
|
¥ 1279.92
|
现货 |
|
0 |
阿拉丁 |
|
Pamrevlumab (anti-CTGF)
|
Ab169278-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
946415-13-0 |
10mg
|
¥ 7599.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Brodalumab (anti-IL17RA)
|
Ab169276-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1174395-19-7 |
5mg
|
¥ 4109.9
|
现货 |
|
0 |
阿拉丁 |
|
Brodalumab (anti-IL17RA)
|
Ab169276-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1174395-19-7 |
1mg
|
¥ 1689.9
|
现货 |
|
0 |
阿拉丁 |
|
Brodalumab (anti-IL17RA)
|
Ab169276-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1174395-19-7 |
10mg
|
¥ 6169.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Risankizumab (anti-IL-23)
|
Ab169268-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1612838-76-2 |
5mg
|
¥ 14069.9
|
现货 |
|
0 |
阿拉丁 |
|
Risankizumab (anti-IL-23)
|
Ab169268-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1612838-76-2 |
1mg
|
¥ 4847.92
|
现货 |
|
0 |
阿拉丁 |
|
Risankizumab (anti-IL-23)
|
Ab169268-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1612838-76-2 |
10mg
|
¥ 21109.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Necitumumab (anti-EGFR)
|
Ab169264-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
906805-06-9 |
5mg
|
¥ 6369.9
|
现货 |
|
0 |
阿拉丁 |
|
Necitumumab (anti-EGFR)
|
Ab169264-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
906805-06-9 |
1mg
|
¥ 1503.92
|
现货 |
|
0 |
阿拉丁 |
|
Necitumumab (anti-EGFR)
|
Ab169264-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
906805-06-9 |
10mg
|
¥ 9559.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Evinacumab (anti-ANGPTL3)
|
Ab169262-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1446419-85-7 |
5mg
|
¥ 18669.9
|
现货 |
|
0 |
阿拉丁 |
|
Evinacumab (anti-ANGPTL3)
|
Ab169262-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1446419-85-7 |
1mg
|
¥ 4655.92
|
现货 |
|
0 |
阿拉丁 |
|
Evinacumab (anti-ANGPTL3)
|
Ab169262-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1446419-85-7 |
10mg
|
¥ 27999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
BrdU Mouse mAb
|
Ab169026-50μl
|
无载体, ExactAb™, 无叠氮钠, 已验证, 见COA |
N/A |
50μl
|
¥ 599.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
BrdU Mouse mAb
|
Ab169026-1ml
|
无载体, ExactAb™, 无叠氮钠, 已验证, 见COA |
N/A |
1ml
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
BrdU Mouse mAb
|
Ab169026-100μl
|
无载体, ExactAb™, 无叠氮钠, 已验证, 见COA |
N/A |
100μl
|
¥ 929.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Recombinant Rat IL-6 Protein
|
rp155124-50μg
|
ActiBioPure™, Bioactive, Animal Free, Carrier Free, Azide Free, High performance, ≥96%(SDS-PAGE&HPLC) |
N/A |
50μg
|
¥ 1303.92
|
现货 |
|
0 |
阿拉丁 |
|
Recombinant Rat IL-6 Protein
|
rp155124-1mg
|
ActiBioPure™, Bioactive, Animal Free, Carrier Free, Azide Free, High performance, ≥96%(SDS-PAGE&HPLC) |
N/A |
1mg
|
¥ 15969.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Recombinant Rat IL-6 Protein
|
rp155124-10μg
|
ActiBioPure™, Bioactive, Animal Free, Carrier Free, Azide Free, High performance, ≥96%(SDS-PAGE&HPLC) |
N/A |
10μg
|
¥ 375.92
|
现货 |
|
0 |
阿拉丁 |
|
Recombinant Rat IL-6 Protein
|
rp155124-100μg
|
ActiBioPure™, Bioactive, Animal Free, Carrier Free, Azide Free, High performance, ≥96%(SDS-PAGE&HPLC) |
N/A |
100μg
|
¥ 2279.9
|
现货 |
|
0 |
阿拉丁 |
|
Recombinant Human Lipocalin-2/NGAL Protein
|
rp148318-50μg
|
ActiBioPure™, Bioactive, Animal Free, Carrier Free, Azide Free, ≥97%(SDS-PAGE) |
N/A |
50μg
|
¥ 1969.9
|
现货 |
|
0 |
阿拉丁 |